COVID-19 Viral and Serology Testing in New York City Health Care Workers
Open Access
- 11 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 154 (5) , 592-595
Abstract
While data continue to emerge around prevalence rates of coronavirus disease 2019 (COVID-19) in the general population, there is limited understanding of infection rates among health care workers (HCWs), a particularly important component of the response to this pandemic as more areas of the world experience surges in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates.1-3 Viral testing through reverse transcription polymerase chain reaction (RT-PCR) demonstrates active infection, whereas serologic testing for SARS-CoV-2 may answer epidemiologic questions about the prevalence of COVID-19, especially in areas where viral testing has been limited.4,5 Here we provide data showing SARS-CoV-2 antibody prevalence in HCWs working in a hospital in New York City (NYC) during the early pandemic in the United States.Keywords
This publication has 6 references indexed in Scilit:
- SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassaysClinica Chimica Acta, 2020
- Clinical Performance of SARS-CoV-2 Molecular TestsJournal of Clinical Microbiology, 2020
- Hospitalization and Mortality among Black Patients and White Patients with Covid-19New England Journal of Medicine, 2020
- Multivariate Analysis of Black Race and Environmental Temperature on COVID-19 in the USThe American Journal of the Medical Sciences, 2020
- The impact of ethnicity on clinical outcomes in COVID-19: A systematic revieweClinicalMedicine, 2020
- COVID-19 and African AmericansJAMA, 2020